FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Hospira Ketorolac Tromethamine Inj Recall

Ketorolac Tromethamine Inj

Hospira, Inc. · Lake Forest, IL

Risk level
Class II
Reported by FDA
Sep 4, 2013
Recall ID
D-926-2013
Check your lot numberHow we source this data

Summary

Hospira recalled Ketorolac Tromethamine Inj starting Aug 12, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-926-2013 on Sep 4, 2013. Reason: Lack of Assurance of Sterility: Either a loose crimp or no crimp was applied to the fliptop vials. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: Either a loose crimp or no crimp was applied to the fliptop vials.

Product description

Ketorolac Tromethamine Inj., USP, 30 mg vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-3795-01

Lot numbers, UPCs & expiration codes

Lot 25048DK Exp. 01/15

Where it was sold

Naitonwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-926-2013
Classification
Class II
Status
Terminated
Recall initiated
Aug 12, 2013
FDA report date
Sep 4, 2013
Quantity
345,800 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Hospira, Inc.

Original FDA data

Every field from FDA enforcement report D-926-2013, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
66050
Address
600 N Field Dr Bldg J45
Code information
Lot 25048DK Exp. 01/15
Postal code
60045
Report date
Sep 4, 2013
Product type
Drugs
Recall number
D-926-2013
Classification
Class II
Recalling firm
Hospira, Inc.
Product quantity
345,800 vials
Termination date
Oct 28, 2014
Reason for recall
Lack of Assurance of Sterility: Either a loose crimp or no crimp was applied to the fliptop vials.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ketorolac Tromethamine Inj., USP, 30 mg vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-3795-01
Distribution pattern
Naitonwide
Recall initiation date
Aug 12, 2013
Initial firm notification
Letter
Center classification date
Aug 28, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-926-2013, published Sep 4, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls